HBIO vs ICCC
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Jul 16, 2026
HBIO
ICCC
Investment Advisor Scores
ICCC
AI Analyst Insights
Detailed Metrics Comparison
| Metric | HBIO | ICCC | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 15.0602 | 0 | Tie |
| PEG Ratio | 1.3059 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -4.7% | 28.4% | ICCC |
| Earnings Growth | -80.3% | 31.3% | ICCC |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 56.7/100 | 60.0/100 | ICCC |
| Profit Margin | -11.4% | -1.8% | ICCC |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
HBIO
NeutralMixed signals - no dominant trend phase, RSI 50
ICCC
MarkupPrice above SMA50, rising 50-day trend (10.4% over 20 days), RSI 57
Fundamentals Snapshot
| Metric | HBIO | ICCC |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 13.9 | 0.0 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.3% |
| Gross Margin | 0.6% | 0.4% |
| Operating Margin | 0.0% | 0.2% |
| EPS | -2.15 | -0.07 |
| Dividend Yield | — | — |